FluoGuide A/S (STO:FLUO)
Sweden · Delayed Price · Currency is SEK 42.30
-1.30 (-2.98%)
Mar 23, 2026, 3:23 PM CET
FluoGuide Market Cap
FluoGuide has a market cap or net worth of 712.83 million as of March 23, 2026. Its market cap has increased by 20.87% in one year.
Market Cap
712.83M
Enterprise Value
639.63M
Revenue
318.79K
Ranking
n/a
PE Ratio
n/a
Stock Price
42.30
Market Cap Chart
Since May 13, 2019, FluoGuide's market cap has increased from 40.02M to 712.83M, an increase of 1,681.07%. That is a compound annual growth rate of 52.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 712.83M | 27.11% |
| Dec 30, 2025 | 560.78M | 5.17% |
| Dec 30, 2024 | 533.23M | -28.57% |
| Dec 29, 2023 | 746.52M | 68.50% |
| Dec 30, 2022 | 443.04M | -54.38% |
| Dec 30, 2021 | 971.21M | 4.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioInvent International AB | 1.43B |
| Medivir AB | 1.16B |
| Xspray Pharma AB | 1.11B |
| Genovis AB (publ.) | 1.07B |
| Cantargia AB | 959.64M |
| SynAct Pharma AB | 945.31M |
| Infant Bacterial Therapeutics AB | 649.32M |
| Oncopeptides AB | 591.35M |